Polymeric nanoparticles—Promising carriers for cancer therapy
Open accessThe DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Abstract
Polymeric nanoparticles (NPs) play an important role in controlled cancer drug delivery. Anticancer drugs can be conjugated or encapsulated by polymeric nanocarriers, which are known as polymeric nanomedicine. Polymeric nanomedicine has shown its potential in providing sustained release of drugs with reduced cytotoxicity and modified tumor retention, but until now, few delivery systems loading drugs have been able to meet clinical demands, so more efforts are needed. This research reviews the current state of the cancer drug-loading system by exhibiting a series of published articles that highlight the novelty and functions from a variety of different architectures including micelles, liposomes, dendrimers, polymersomes, hydrogels, and metal–organic frameworks. These may contribute to the development of useful polymeric NPs to achieve different therapeutic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Chemistry and Applications of Metal-Organic Frameworks
Furukawa, H., Cordova, K. E., O’Keeffe, M., & Yaghi, O. M. (2013) · Science · doi:10.1126/science.1230444 · Cited by 16,945
Hydrogel nanoparticles in drug delivery
Hamidi, M., Azadi, A., & Rafiei, P. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.002 · Cited by 2,067
Taylor-Pashow, K. M. L., Della Rocca, J., Xie, Z., Tran, S., & Lin, W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906198y · Cited by 1,522
Hrkach, J., Von Hoff, D., Ali, M. M., Andrianova, E., Auer, J., Campbell, T., De Witt, D., Figa, M., Figueiredo, M., Horhota, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003651 · Cited by 1,147
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081 · cited 1×
“NPs can supply efficient therapeutic strategies by improving the bioavailability, stability, and target specificity to reduce side effects and overcome the limitations of conventional treatment methods (Gaumet et al., 2008; Yang et al., 2020; Ndebele et al., 2021).”
BackgroundHe, C., Lu, K., Liu, D., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4098862 · Cited by 885
Nanoscale Coordination Polymers for Platinum-Based Anticancer Drug Delivery
Rieter, W. J., Pott, K. M., Taylor, K. M. L., & Lin, W. (2008) · Journal of the American Chemical Society · doi:10.1021/ja803383k · Cited by 803 · cited 1×
“The group of Lin synthesized Fe(III)-carboxylate nanoscale metal–organic frameworks with high specific surface area by the rapid microwave method (Rieter et al., 2008; Pashow et al., 2009).”
MethodNanoparticles for drug delivery in cancer treatment
Haley, B., & Frenkel, E. (2008) · Urologic Oncology: Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.015 · Cited by 791 · cited 1×
“Nanoparticles (NPs) are promising effective delivery tools as the candidates that overcome the difficulties in clinical applicability (Haley and Frenkel, 2008; Saw and Jon, 2020; Zheng et al., 2021).”
BackgroundStimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Li, H.-J., Du, J.-Z., Du, X.-J., Xu, C.-F., Sun, C.-Y., Wang, H.-X., Cao, Z.-T., Yang, X.-Z., Zhu, Y.-H., Nie, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522080113 · Cited by 724
Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle
Sun, C.-Y., Qin, C., Wang, X.-L., Yang, G.-S., Shao, K.-Z., Lan, Y.-Q., Su, Z.-M., Huang, P., Wang, C.-G., & Wang, E.-B. (2012) · Dalton Transactions · doi:10.1039/c2dt30357d · Cited by 710
pH-Sensitive Vesicles Based on a Biocompatible Zwitterionic Diblock Copolymer
Du, J., Tang, Y., Lewis, A. L., & Armes, S. P. (2005) · Journal of the American Chemical Society · doi:10.1021/ja056514l · Cited by 603 · cited 1×
“For example, in the case of poly (2-(methacryloyloxy)ethyl phosphorylcholine)-bpoly (2-(diisoprop ylamino) ethylm ethacrylate (PMPCPDPA) polymersomes reported by Du Jian-zhong, when the pH value of the solution altered from 2 to greater than 6, the hydrophobicity of PDPA was enhanced due to the deprotonation of the te…”
BackgroundThe importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594 · cited 1×
“Nowadays, drug-loaded NPs are particularly viable for efficient cancer therapy due to their improved drug delivery and therapeutic effects in various types of cancer (Wang et al., 2010; Rejinold et al., 2011; Truong et al., 2015).”
BackgroundNanoparticle-assisted Combination Therapies for Effective Cancer Treatment
Hu, C.-M. J., Aryal, S., & Zhang, L. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.13 · Cited by 564 · cited 1×
“Broad classes of therapeutics including cytotoxic agents, small interference RNA (siRNA), chemosensitizer, antiangiogenic agents, and so on can be carried by the nanoparticle platforms (Hu et al., 2010; Liao et al., 2014; Lammers and Ferrari, 2020).”
BackgroundMechanised nanoparticles for drug delivery
Cotí, K. K., Belowich, M. E., Liong, M., Ambrogio, M. W., Lau, Y. A., Khatib, H. A., Zink, J. I., Khashab, N. M., & Stoddart, J. F. (2009) · Nanoscale · doi:10.1039/b9nr00162j · Cited by 512
Nanoparticle-Based Immunotherapy for Cancer
Shao, K., Singha, S., Clemente-Casares, X., Tsai, S., Yang, Y., & Santamaria, P. (2015) · ACS Nano · doi:10.1021/nn5062029 · Cited by 470 · cited 1×
“They take the drugs to the right place, at the right concentration with greater efficacy and reduced cytotoxicity in peripheral healthy tissues (Gaitanis and Staal, 2010; Ambasta et al., 2011; Shao et al., 2015).”
BackgroundStimuli-responsive polymer vesicles
Li, M.-H., & Keller, P. (2009) · Soft Matter · doi:10.1039/b815725a · Cited by 464 · cited 1×
“Like their low molecular weight analogues liposomes, they can be stimuli-sensitive (Li and Kellera, 2009; Siegel, 2014).”
BackgroundMin, H., Wang, J., Qi, Y., Zhang, Y., Han, X., Xu, Y., Xu, J., Li, Y., Chen, L., Cheng, K., et al. (2019) · Advanced Materials · doi:10.1002/adma.201808200 · Cited by 394 · cited 1×
“The NMOF is situated mostly in lysosomes against lysosomal degradation for further degradation in the cytosol, and drugs are released and distributed to different cellular organelles (Figure 7) (Min et al., 2019).”
BackgroundAmorphous metal–organic frameworks for drug delivery
Orellana-Tavra, C., Baxter, E. F., Tian, T., Bennett, T. D., Slater, N. K. H., Cheetham, A. K., & Fairen-Jimenez, D. (2015) · Chemical Communications · doi:10.1039/c5cc05237h · Cited by 378
Polymersome carriers: From self-assembly to siRNA and protein therapeutics
Christian, D. A., Cai, S., Bowen, D. M., Kim, Y., Pajerowski, J. D., & Discher, D. E. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.025 · Cited by 371 · cited 1×
“They own spherical single-chamber or multi-chamber structures formed by closed bilayers, which are similar to the structure of cell membranes (Christian et al., 2009; Kim et al., 2009).”
BackgroundNanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 364 · cited 1×
“Polymeric nanocarriers with conjugated or encapsulated anticancer drugs, also known as polymeric nanomedicines, show a variety of different architectures including polymer–drug conjugates, micelles, nanospheres, nanogels, vesicles, and dendrimers (Alexis et al., 2010; Liu et al., 2014) (Figure 1).”
BackgroundSupramolecular engineering of hydrogels for drug delivery
Bernhard, S., & Tibbitt, M. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.002 · Cited by 363
Liao, L., Liu, J., Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Hammond, P. T., & Johnson, J. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja502011g · Cited by 362 · cited 1×
“Broad classes of therapeutics including cytotoxic agents, small interference RNA (siRNA), chemosensitizer, antiangiogenic agents, and so on can be carried by the nanoparticle platforms (Hu et al., 2010; Liao et al., 2014; Lammers and Ferrari, 2020).”
BackgroundJiang, T., Zhang, Z., Zhang, Y., Lv, H., Zhou, J., Li, C., Hou, L., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.027 · Cited by 359
Anitha, A., Maya, S., Deepa, N., Chennazhi, K. P., Nair, S. V., Tamura, H., & Jayakumar, R. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.08.008 · Cited by 347 · cited 1×
“It has been noticed for long that clinical application of many potent remedial drugs in cancer and other diseases have been limited due to the following reasons: 1) poor aqueous solubility, and consequently, minimal systemic bioavailability (Anitha et al., 2011; Tosca et al., 2021).”
BackgroundChen, G., Kou, X., Huang, S., Tong, L., Shen, Y., Zhu, W., Zhu, F., & Ouyang, G. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201913231 · Cited by 347
Metal–Organic Framework Coatings as Cytoprotective Exoskeletons for Living Cells
Liang, K., Richardson, J. J., Cui, J., Caruso, F., Doonan, C. J., & Falcaro, P. (2016) · Advanced Materials · doi:10.1002/adma.201602335 · Cited by 335 · cited 1×
“In recent years, medical researchers have reduced the size of such materials to the nanometer scale (NMOFs) and tried to use them in the fields of biological medicine storage, slow release, biological imaging, and the transmission of gaseous signal molecules (Liang et al., 2016; Wang et al., 2020).”
BackgroundAhmed, F., Pakunlu, R. I., Srinivas, G., Brannan, A., Bates, F., Klein, M. L., Minko, T., & Discher, D. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050103u · Cited by 330
DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells
Wu, Y., Sefah, K., Liu, H., Wang, R., & Tan, W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909611107 · Cited by 330
Abánades Lázaro, I., Wells, C. J. R., & Forgan, R. S. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201915848 · Cited by 326
Dendrimer‐Entrapped Gold Nanoparticles as a Platform for Cancer‐Cell Targeting and Imaging
Shi, X., Wang, S., Meshinchi, S., Van Antwerp, M. E., Bi, X., Lee, I., & Baker, J. R. (2007) · Small · doi:10.1002/smll.200700054 · Cited by 318 · cited 1×
“They are modified by folic acid (FA) and fluorescein isothiocyanate (FI) molecules which are water-soluble, stable, and biocompatible (Shi et al., 2007).”
BackgroundPatil, Y. B., Swaminathan, S. K., Sadhukha, T., Ma, L., & Panyam, J. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.048 · Cited by 304 · cited 1×
“resistance—it is easy to cause multidrug resistance and reduce the effect of further treatment (Patil et al., 2010; Kim et al., 2013).”
BackgroundCao, Y., Zhang, C., Shen, W., Cheng, Z., Yu, L. (., & Ping, Q. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.009 · Cited by 299 · cited 1×
“The hydrophobic segment most commonly used for thermo-sensitive polymer is poly (N-isopropylacrylamide) (PNIPAAm) (Lorenzo et al., 2005; Cao et al., 2007).”
BackgroundNishiyama, N., Morimoto, Y., Jang, W.-D., & Kataoka, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.004 · Cited by 266 · cited 1×
“For instance, the polymeric micelles loading camptothecin (CPT) exhibited photosensitive endosomal escape, which reduced the cytotoxicity of camptothecin on photoirradiation (Nishiyama et al., 2009).”
BackgroundThe blood clearance kinetics and pathway of polymeric micelles in cancer drug delivery
Sun, X., Wang, G., Zhang, H., Hu, S., Liu, X., Tang, J., & Shen, Y. (2018) · ACS Nano · doi:10.1021/acsnano.8b02830 · Cited by 253 · cited 1×
“In general, NPs efficiently carry therapeutics to the target and are stable in vivo (Cotí et al., 2009; Sun et al., 2018; Li et al., 2020).”
BackgroundCurcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery
Sanoj Rejinold, N., Muthunarayanan, M., Divyarani, V. V., Sreerekha, P. R., Chennazhi, K. P., Nair, S. V., Tamura, H., & Jayakumar, R. (2011) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2011.04.006 · Cited by 247 · cited 1×
“Nowadays, drug-loaded NPs are particularly viable for efficient cancer therapy due to their improved drug delivery and therapeutic effects in various types of cancer (Wang et al., 2010; Rejinold et al., 2011; Truong et al., 2015).”
BackgroundKim, K.-R., Kim, D.-R., Lee, T., Yhee, J. Y., Kim, B.-S., Kwon, I. C., & Ahn, D.-R. (2013) · Chemical Communications · doi:10.1039/c3cc38693g · Cited by 246 · cited 1×
“resistance—it is easy to cause multidrug resistance and reduce the effect of further treatment (Patil et al., 2010; Kim et al., 2013).”
BackgroundCoordination polymer particles as potential drug delivery systems
Imaz, I., Rubio-Martínez, M., García-Fernández, L., García, F., Ruiz-Molina, D., Hernando, J., Puntes, V., & Maspoch, D. (2010) · Chemical Communications · doi:10.1039/c003084h · Cited by 246 · cited 1×
“chose doxorubicin, camptothecin, and several other anticancer drugs to be loaded by MOFs through the selfassembly process (Imaz et al., 2010).”
BackgroundWu, X. L., Kim, J. H., Koo, H., Bae, S. M., Shin, H., Kim, M. S., Lee, B.-H., Park, R.-W., Kim, I.-S., Choi, K., et al. (2010) · Bioconjugate Chemistry · doi:10.1021/bc9005283 · Cited by 239
Temperature-sensitive hydrogels with SiO2–Au nanoshells for controlled drug delivery
Bikram, M., Gobin, A. M., Whitmire, R. E., & West, J. L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.013 · Cited by 238
Yang, X., Grailer, J. J., Pilla, S., Steeber, D. A., & Gong, S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900422j · Cited by 206
Peng, Z., Zou, Y., Xu, S., Zhong, W., & Yang, W. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b05171 · Cited by 198 · cited 2×
“In addition to these, pressure-sensitive, specific ionsensitive, and antigen-responsive hydrogels were all studied (Ikeda et al., 2010; Liu et al., 2013; Peng et al., 2018).”
BackgroundMethodInfluence of nanomedicine mechanical properties on tumor targeting delivery
Li, Z., Xiao, C., Yong, T., Li, Z., Gan, L., & Yang, X. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00575g · Cited by 196
Alvarez-Lorenzo, C., Concheiro, A., Dubovik, A. S., Grinberg, N. V., Burova, T. V., & Grinberg, V. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.021 · Cited by 195
Challenges and Opportunities of Nanomedicines in Clinical Translation
Zheng, C., Li, M., & Ding, J. (2021) · BIO Integration · doi:10.15212/bioi-2021-0016 · Cited by 194 · cited 1×
“Nanoparticles (NPs) are promising effective delivery tools as the candidates that overcome the difficulties in clinical applicability (Haley and Frenkel, 2008; Saw and Jon, 2020; Zheng et al., 2021).”
BackgroundPeptide-based supramolecular hydrogels for local drug delivery
Zhang, Z., Ai, S., Yang, Z., & Li, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.010 · Cited by 191
Agut, W., Brûlet, A., Schatz, C., Taton, D., & Lecommandoux, S. (2010) · Langmuir · doi:10.1021/la1005693 · Cited by 185 · cited 1×
“To date, the chemical bonds rapidly hydrolyzing under acidic conditions are hydrazone, βcarboxamide, ester bonds, and so on (Agut et al., 2010; Lee et al., 2014; Shi et al., 2015).”
BackgroundPolymersome delivery of siRNA and antisense oligonucleotides
Kim, Y., Tewari, M., Pajerowski, J. D., Cai, S., Sen, S., Williams, J., Sirsi, S., Lutz, G., & Discher, D. E. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.10.020 · Cited by 184 · cited 1×
“They own spherical single-chamber or multi-chamber structures formed by closed bilayers, which are similar to the structure of cell membranes (Christian et al., 2009; Kim et al., 2009).”
BackgroundBiomimetic Liposome- and Polymersome-Based Multicompartmentalized Assemblies
Chandrawati, R., & Caruso, F. (2012) · Langmuir · doi:10.1021/la301958v · Cited by 179 · cited 1×
“Because the structure of polymersomes is similar to that of liposomes, they have a hydrophilic inner cavity and a hydrophobic membrane bilayer (Chandrawati and Caruso, 2012).”
BackgroundA cancer-recognizable MRI contrast agents using pH-responsive polymeric micelle
Kim, K. S., Park, W., Hu, J., Bae, Y. H., & Na, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.004 · Cited by 173 · cited 1×
“pH-responsive polymer micelles are mainly prepared by selfassembly of amphiphilic blocks or grafted copolymers (Basak and Ghosh, 2013; Kim et al., 2014).”
BackgroundAntoni, P., Robb, M. J., Campos, L., Montanez, M., Hult, A., Malmström, E., Malkoch, M., & Hawker, C. J. (2010) · Macromolecules · doi:10.1021/ma101242u · Cited by 171
Targeting drug delivery with light: A highly focused approach
Rapp, T. L., & DeForest, C. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.009 · Cited by 160 · cited 2×
“On exposure to light of appropriate wavelengths, the photosensitizers lead to the formation of reactive oxygen and therefore trigger the disruption of endosomal or lysosomal membranes (Ding et al., 2013; Xia et al., 2018; Rapp and Deforest, 2021).”
BackgroundDing, J., Chen, J., Li, D., Xiao, C., Zhang, J., He, C., Zhuang, X., & Chen, X. (2012) · Journal of Materials Chemistry B · doi:10.1039/c2tb00063f · Cited by 154 · cited 1×
“On exposure to light of appropriate wavelengths, the photosensitizers lead to the formation of reactive oxygen and therefore trigger the disruption of endosomal or lysosomal membranes (Ding et al., 2013; Xia et al., 2018; Rapp and Deforest, 2021).”
BackgroundSelf-citationThermal response of low molecular weight poly-(N-isopropylacrylamide) polymers in aqueous solution
Pamies, R., Zhu, K., Kjøniksen, A., & Nyström, B. (2008) · Polymer Bulletin · doi:10.1007/s00289-008-0029-4 · Cited by 150 · cited 1×
“So far, the blocks have been used for thermo-sensitive polymersomes including poly (N-(3aminopropy1)-methacrylamide hydrochloride)-b-PNIPAAm, poly (2-einnamoylethyl methacrylate)-b-PNIPAAm, PEGPNIPAAm, and so on (Pamies et al., 2009; Zhang et al., 2011; Quan et al., 2013).”
MethodLu, H.-L., Syu, W.-J., Nishiyama, N., Kataoka, K., & Lai, P. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.005 · Cited by 146
Wang, X., Xu, L., Li, M., & Zhang, X. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202008858 · Cited by 144
Stimuli sensitive polymers and self regulated drug delivery systems: A very partial review
Siegel, R. A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.035 · Cited by 143 · cited 1×
“Like their low molecular weight analogues liposomes, they can be stimuli-sensitive (Li and Kellera, 2009; Siegel, 2014).”
BackgroundSelf-Assembly and Micellization of a Dual Thermoresponsive Supramolecular Pseudo-Block Copolymer
Zhang, Z.-X., Liu, K. L., & Li, J. (2011) · Macromolecules · doi:10.1021/ma102196q · Cited by 138 · cited 1×
“So far, the blocks have been used for thermo-sensitive polymersomes including poly (N-(3aminopropy1)-methacrylamide hydrochloride)-b-PNIPAAm, poly (2-einnamoylethyl methacrylate)-b-PNIPAAm, PEGPNIPAAm, and so on (Pamies et al., 2009; Zhang et al., 2011; Quan et al., 2013).”
MethodReversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles
Yu, P., Yu, H., Guo, C., Cui, Z., Chen, X., Yin, Q., Zhang, P., Yang, X., Cui, H., & Li, Y. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.12.001 · Cited by 137
Micellar Transition State in Casein Between pH 5.5 and 5.0
Gastaldi, E., Lagaude, A., & FUENTE, B. T. D. L. (1996) · Journal of Food Science · doi:10.1111/j.1365-2621.1996.tb14725.x · Cited by 131 · cited 1×
“The pH of the transition state from insolubility to solubility (pHT) can be adjusted by the substituents (Gastaldi et al., 1996).”
BackgroundHu, J., Miura, S., Na, K., & Bae, Y. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.007 · Cited by 128
A protein@metal–organic framework nanocomposite for pH-triggered anticancer drug delivery
Liang, Z., Yang, Z., Yuan, H., Wang, C., Qi, J., Liu, K., Cao, R., & Zheng, H. (2018) · Dalton Transactions · doi:10.1039/c8dt01789a · Cited by 128
Liu, Y., Feng, L., Liu, T., Zhang, L., Yao, Y., Yu, D., Wang, L., & Zhang, N. (2014) · Nanoscale · doi:10.1039/c3nr05647c · Cited by 126 · cited 1×
“Polymeric nanocarriers with conjugated or encapsulated anticancer drugs, also known as polymeric nanomedicines, show a variety of different architectures including polymer–drug conjugates, micelles, nanospheres, nanogels, vesicles, and dendrimers (Alexis et al., 2010; Liu et al., 2014) (Figure 1).”
BackgroundAsad, M. I., Khan, D., Rehman, A. U., et al. (2021) · Nanomaterials · doi:10.3390/nano11123433 · Cited by 124 · cited 1×
“In addition, there are other strategies including adding pH-sensitive groups to improve drug efficacy (Asad et al., 2021).”
BackgroundElectroresponsive Polymer–Carbon Nanotube Hydrogel Hybrids for Pulsatile Drug Delivery In Vivo
Servant, A., Methven, L., Williams, R., & Kostarelos, K. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200193 · Cited by 122
Diblock copolymers with tunable pH transitions for gene delivery
Manganiello, M. J., Cheng, C., Convertine, A. J., Bryers, J. D., & Stayton, P. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.019 · Cited by 122
Omidi, S., Pirhayati, M., & Kakanejadifard, A. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115745 · Cited by 118
Jiang, T., Qiao, Y., Ruan, W., Zhang, D., Yang, Q., Wang, G., Chen, Q., Zhu, F., Yin, J., Zou, Y., et al. (2021) · Advanced Materials · doi:10.1002/adma.202104779 · Cited by 117
Purushottamachar, P., Godbole, A. M., Gediya, L. K., Martin, M. S., Vasaitis, T. S., Kwegyir‐Afful, A. K., Ramalingam, S., Ateş‐Alagöz, Z., & Njar, V. C. O. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400048v · Cited by 115 · cited 1×
“Therein, a targeting strategy as a multitargeting system (MTS) has attracted extensive attention (Purushottamachar et al., 2013).”
BackgroundMultifunctional drug delivery system for targeting tumor and its acidic microenvironment
Shen, M., Huang, Y., Han, L., Qin, J., Fang, X., Wang, J., & Yang, V. C.-M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.013 · Cited by 110 · cited 1×
“But the lack of a vascular system in tumor cells does not allow the lactic acid to be excreted completely, which leads to the acidic environment in tumor cells (Crayton and Tsourkas, 2011; Shen et al., 2012).”
BackgroundLammers, T., & Ferrari, M. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100853 · Cited by 107 · cited 1×
“Broad classes of therapeutics including cytotoxic agents, small interference RNA (siRNA), chemosensitizer, antiangiogenic agents, and so on can be carried by the nanoparticle platforms (Hu et al., 2010; Liao et al., 2014; Lammers and Ferrari, 2020).”
BackgroundThermo-sensitive switching membranes regulated by pore-covering polymer brushes
Yang, B., & Yang, W. (2003) · Journal of Membrane Science · doi:10.1016/s0376-7388(03)00182-0 · Cited by 102 · cited 2×
“They can release the DOX most at 41°C. Biao Yang prepared the pore-covering polymer brushes by PNIPAAm onto the PET (Yang and Yang, 2003).”
BackgroundMethodHybrid nanogels for sustainable positive thermosensitive drug release
Shin, Y., Chang, J. H., Liu, J., Williford, R. E., Shin, Y.-K., & Exarhos, G. J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00247-4 · Cited by 97 · cited 1×
“For example, the temperature-sensitive hydrogels based on the interpenetrating network of PNIPAAm was immobilized on porous silica gel and hydroxyapatite (Shin et al., 2001; Shin et al., 2002).”
BackgroundPangburn, T. O., Georgiou, K., Bates, F. S., & Kokkoli, E. (2012) · Langmuir · doi:10.1021/la300874z · Cited by 91 · cited 1×
“The polymersomes are self-assembled by the synthetic or natural modified amphiphilic polymers (Pangburn et al., 2012).”
BackgroundMMPs-specific PEGylated peptide–DOX conjugate micelles that can contain free doxorubicin
Lee, G. Y., Park, K., Kim, S. Y., & Byun, Y. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.023 · Cited by 91 · cited 1×
“In addition to all the above, temperature-sensitive and enzyme-responsive micelles are also studied and show the potential to reach improved antitumor efficiency (Lee et al., 2007).”
BackgroundLiposomal Doxorubicin and nab-Paclitaxel: Nanoparticle Cancer Chemotherapy in Current Clinical Use
Gaitanis, A., & Staal, S. P. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-609-2_26 · Cited by 88 · cited 1×
“They take the drugs to the right place, at the right concentration with greater efficacy and reduced cytotoxicity in peripheral healthy tissues (Gaitanis and Staal, 2010; Ambasta et al., 2011; Shao et al., 2015).”
BackgroundIkeda, M., Ochi, R., Wada, A., & Hamachi, I. (2010) · Chemical Science · doi:10.1039/c0sc00278j · Cited by 88 · cited 1×
“In addition to these, pressure-sensitive, specific ionsensitive, and antigen-responsive hydrogels were all studied (Ikeda et al., 2010; Liu et al., 2013; Peng et al., 2018).”
BackgroundCabral, H., Nakanishi, M., Kumagai, M., Jang, W., Nishiyama, N., & Kataoka, K. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9712-2 · Cited by 84
Light‐Sensitive Polypeptide Hydrogel and Nanorod Composites
Charati, M. B., Lee, I. Y., Hribar, K. C., & Burdick, J. A. (2010) · Small · doi:10.1002/smll.201000162 · Cited by 84
Extracellular Vesicles: Emerging Modulators of Cancer Drug Resistance
Fontana, F., Carollo, E., Melling, G. E., & Carter, D. R. F. (2021) · Cancers · doi:10.3390/cancers13040749 · Cited by 83 · cited 1×
“2) Instability in vivo—the drugs are dispersible in the whole living body and tend to be metabolized and eliminated, which causes the change of drug concentration in vivo and reduces its efficacy (Marczynski et al., 2021; Fontana et al., 2021).”
BackgroundSoltantabar, P., Calubaquib, E. L., Mostafavi, E., Biewer, M. C., & Stefan, M. C. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01742 · Cited by 83 · cited 1×
“Its hydrophobic core is capable of packaging various hydrophobic drugs, such as cisplatin, doxorubicin, camptothecin, paclitaxel, and so on (Wu Y. et al., 2010; Soltantabar et al., 2020).”
BackgroundIn vitro antibacterial activity of poly (amidoamine)-G7 dendrimer
Gholami, M., Mohammadi, R., Arzanlou, M., Dourbash, F. A., Kouhsari, E., Majidi, G., Mohseni, S. M., & Nazari, S. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2513-7 · Cited by 82 · cited 1×
“PAMAM-G7 reported by Mitra Gholami was synthesized by the divergent growth method (Gholami et al., 2017), and a 6th generation dendrimer was synthesized in a single day by Per Antoni through the divergent growth method (Antoni et al.”
MethodYan, L., Wu, W., Zhao, W. M., Qi, R., Cui, D., Xie, Z., Huang, Y., Tong, T., & Jing, X. (2012) · Polymer Chemistry · doi:10.1039/c2py20240a · Cited by 79
Lee, S. Y., Lee, H., In, I., & Park, S. Y. (2014) · European Polymer Journal · doi:10.1016/j.eurpolymj.2014.04.020 · Cited by 78
Liu, X., Wu, J., Yammine, M., Zhou, J., Posocco, P., Viel, S., Liu, C., Ziarelli, F., Fermeglia, M., Pricl, S., et al. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200275g · Cited by 76
Vamvakaki, M., Papoutsakis, L., Katsamanis, V., Afchoudia, T., Fragouli, P. G., Iatrou, H., Hadjichristidis, N., Armes, S. P., Sidorov, S., Zhirov, D., et al. (2005) · Faraday Discussions · doi:10.1039/b403414g · Cited by 72 · cited 1×
“Poly (N,N-diethylaminoethyl methacrylate) (PDEA), poly (4- or 2-vinylpyridine) (PVP), poly (L-histidine) (PHis), and poly (β-amino ester) (PbAE) are the most common alkalescence copolymers (Figure 2) (Vamvakaki et al., 2005; Manganiello et al., 2012; Cai et al., 2015).”
BackgroundYu, H., Xu, Z., Chen, X., Xu, L., Yin, Q., Zhang, Z., & Li, Y. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201300282 · Cited by 70 · cited 1×
“, aptamer), antibodies, and other tumor-targeting groups to the surface of the micelles, or through the combination with magnetic nanoparticles, micelles may even target tumor proactively (Chen et al., 2013; Yu et al., 2014; Yu Z. et al., 2015).”
BackgroundpH-Responsive Amphiphilic Polyether Micelles with Superior Stability for Smart Drug Delivery
Son, I., Lee, Y., Baek, J., Park, M.-R., Han, D., Min, S. K., Lee, D., & Kim, B. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00163 · Cited by 68
Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy
Ambasta, R. K., Sharma, A., & Kumar, P. (2011) · Vascular Cell · doi:10.1186/2045-824x-3-26 · Cited by 66 · cited 1×
“They take the drugs to the right place, at the right concentration with greater efficacy and reduced cytotoxicity in peripheral healthy tissues (Gaitanis and Staal, 2010; Ambasta et al., 2011; Shao et al., 2015).”
BackgroundXia, J., Du, Y., Huang, L., Chaurasiya, B., Tu, J., Webster, T. J., & Sun, C. (2018) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2017.12.017 · Cited by 63
Delivering a photosensitive transplatin prodrug to overcome cisplatin drug resistance
Song, H., Li, W., Qi, R., Yan, L., Jing, X., Zheng, M., & Xiao, H. (2015) · Chemical Communications · doi:10.1039/c5cc03692e · Cited by 54 · cited 1×
“Moreover, photosensitive platinum drugs can overcome the resistance of cisplatin (Hai et al., 2015).”
BackgroundSelf-citationSynthesis and Characterization of Thermo-Sensitive Nanoparticles for Drug Delivery Applications
Rahimi, M., Kilaru, S., Sleiman, G. E. H., Saleh, A. W., Rudkevich, D. M., & Nguyen, K. T. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.014 · Cited by 53 · cited 1×
“Thermo-sensitive poly (N-isopropylacrylamide-co-acrylamide- coallylamine) (NIPAAAm-AH) polymersomes reported by Maham Rahimi with lower LCST can be incorporated with various molecules at the surface (Rahimi et al., 2008).”
BackgroundNanobiohybrids: A Synergistic Integration of Bacteria and Nanomaterials in Cancer Therapy
Chen, Y., Du, M., Yu, J., Rao, L., Chen, X. S., & Chen, Z. (2020) · BIO Integration · doi:10.15212/bioi-2020-0008 · Cited by 51
Shi, Y., van Nostrum, C. F., & Hennink, W. E. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00006 · Cited by 50
Purified mucins in drug delivery research
Marczynski, M., Kımna, C., & Lieleg, O. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113845 · Cited by 49 · cited 1×
“2) Instability in vivo—the drugs are dispersible in the whole living body and tend to be metabolized and eliminated, which causes the change of drug concentration in vivo and reduces its efficacy (Marczynski et al., 2021; Fontana et al., 2021).”
BackgroundBasak, D., & Ghosh, S. (2013) · ACS Macro Letters · doi:10.1021/mz400357g · Cited by 48 · cited 1×
“pH-responsive polymer micelles are mainly prepared by selfassembly of amphiphilic blocks or grafted copolymers (Basak and Ghosh, 2013; Kim et al., 2014).”
BackgroundCai, M., Leng, M., Lu, A., Liu, H., Xie, X., Huang, L., Ma, Y., Cao, J., Chen, Y., & Luo, X. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.12.005 · Cited by 46 · cited 1×
“Poly (N,N-diethylaminoethyl methacrylate) (PDEA), poly (4- or 2-vinylpyridine) (PVP), poly (L-histidine) (PHis), and poly (β-amino ester) (PbAE) are the most common alkalescence copolymers (Figure 2) (Vamvakaki et al., 2005; Manganiello et al., 2012; Cai et al., 2015).”
BackgroundChen, D., Song, P., Jiang, F., Meng, X., Sui, W., Shu, C., & Wan, L. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp310677p · Cited by 42
Self-citationChen, G., Kou, X., Huang, S., Tong, L., Shen, Y., Zhu, W., Zhu, F., & Ouyang, G. (2019) · Angewandte Chemie · doi:10.1002/ange.201913231 · Cited by 38
Hydrogen sulfide-releasing micelles for promoting angiogenesis
Chen, J. J. Y., van der Vlies, A. J., & Hasegawa, U. (2020) · Polymer Chemistry · doi:10.1039/d0py00495b · Cited by 35
Self-citationNdebele, R. T., Yao, Q., Shi, Y., Zhai, Y., Xu, H., Lu, C., & Zhao, Y. (2021) · BIO Integration · doi:10.15212/bioi-2021-0028 · Cited by 34 · cited 1×
“NPs can supply efficient therapeutic strategies by improving the bioavailability, stability, and target specificity to reduce side effects and overcome the limitations of conventional treatment methods (Gaumet et al., 2008; Yang et al., 2020; Ndebele et al., 2021).”
BackgroundDu, R., Xiao, H., Guo, G., Jiang, B., Yan, X., Li, W., Yang, X., Zhang, Y. X., Li, Y., & Jing, X. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.10.015 · Cited by 33 · cited 1×
“The synthesized NP-UVA-Pt2 can be actively transported by tumor endocytosis, activated under UVA irradiation, and can release cisplatin to eliminate the tumor (Rong et al., 2014).”
BackgroundSelf-citationApplication of Artificial Neural Networks to Predict the Intrinsic Solubility of Drug-Like Molecules
Tosca, E. M., Bartolucci, R., & Magni, P. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071101 · Cited by 31 · cited 1×
“It has been noticed for long that clinical application of many potent remedial drugs in cancer and other diseases have been limited due to the following reasons: 1) poor aqueous solubility, and consequently, minimal systemic bioavailability (Anitha et al., 2011; Tosca et al., 2021).”
BackgroundGonzález‐Ayón, M. A., Sañudo‐Barajas, J. A., Picos‐Corrales, L. A., & Licea‐Claveríe, A. (2015) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.27766 · Cited by 31 · cited 1×
“In vitro drug release and in vivo pharmacodynamics were examined in detail (Ayon et al., 2015).”
BackgroundSarfraz, R. M., Akram, M. R., Ali, M., Mahmood, A., Khan, M. U., Ahmad, H., & Qaisar, M. N. (2019) · Advances in Polymer Technology · doi:10.1155/2019/6090965 · Cited by 27
Xue, P.-P., Yuan, J.-D., Yao, Q., Zhao, Y.-Z., & Xu, H.-L. (2020) · BIO Integration · doi:10.15212/bioi-2020-0010 · Cited by 27 · cited 1×
“Hydrogels composed of 3D hydrophilic polymer chains have unique configurations and adjustable physicochemical properties (Peng et al., 2020).”
BackgroundDendritic Macromolecular Architectures: Dendrimer-Based Polyion Complex Micelles
Mignani, S. M., Shi, X., Zabłocka, M., & Majoral, J. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.0c01645 · Cited by 26 · cited 1×
“The polymeric micelle delivery of anticancer drugs improve the tumor targeting of drugs and reduce the drug resistance, which has aroused extensive research interest in recent years (Chen J. J. Y. et al., 2020; Mignani et al., 2021; Son et al., 2021).”
BackgroundAlemayehu, Y. A., Gebeyehu, B. T., & Cheng, C. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01322 · Cited by 24 · cited 1×
“The photosensitive supramolecular drug-loaded irradiated micelles had more potent cytotoxic effects against cancer cells exhibiting much higher cellular uptake efficiency (Figure 4) (Alemayehu et al., 2019).”
BackgroundNanoparticle Drug Delivery Can Reduce the Hepatotoxicity of Therapeutic Cargo
Yang, F., Medik, Y. B., Li, L., Tian, X., Fu, D., Brouwer, K. L. R., Wagner, K., Sun, B., Sendi, H., Mi, Y., et al. (2020) · Small · doi:10.1002/smll.201906360 · Cited by 24 · cited 1×
“NPs can supply efficient therapeutic strategies by improving the bioavailability, stability, and target specificity to reduce side effects and overcome the limitations of conventional treatment methods (Gaumet et al., 2008; Yang et al., 2020; Ndebele et al., 2021).”
BackgroundHori, K., Nishihara, M., & Yokoyama, M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21848 · Cited by 21 · cited 1×
“Through the enhanced permeability and retention (EPR) effect, drugs will be accumulated in tumor tissue passively (Hori et al., 2010; Liu T. J. et al., 2011; Zhao et al., 2020).”
BackgroundLu, J., Hu, P., Cao, L., Wei, Z., Xiao, F., Chen, Z., Li, Y., & Tian, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202012916 · Cited by 21 · cited 1×
“nanomedicine constructed by the flexible 3-arm building blocks with a highly efficient one-pot DNA assembly was designed (Figure 5) (Lu et al., 2021).”
BackgroundQuan, Z., Zhu, K., Knudsen, K. D., Nyström, B., & Lund, R. (2013) · Soft Matter · doi:10.1039/c3sm51945g · Cited by 20 · cited 1×
“So far, the blocks have been used for thermo-sensitive polymersomes including poly (N-(3aminopropy1)-methacrylamide hydrochloride)-b-PNIPAAm, poly (2-einnamoylethyl methacrylate)-b-PNIPAAm, PEGPNIPAAm, and so on (Pamies et al., 2009; Zhang et al., 2011; Quan et al., 2013).”
MethodLiu, J., Xu, M., & Yuan, Z. (2020) · BIO Integration · doi:10.15212/bioi-2020-0002 · Cited by 18 · cited 1×
“They attract more attention for their ability to co-deliver multiple therapeutic agents and to target the tumor cells (Liu et al., 2020).”
BackgroundDeng, Y., Huang, R., Huang, S., & Xiong, M. (2021) · BIO Integration · doi:10.15212/bioi-2021-0003 · Cited by 18 · cited 1×
“3) Toxic side effects—the drugs are always toxic to the normal cells at the same time, including nephrotoxicity, neurovirulence, and gastrointestinal reactions (Chen Y. et al., 2020; Deng et al., 2021).”
BackgroundRehman, U., Sarfraz, R. M., Mahmood, A., Hussain, Z., Thu, H. E., Zafar, N., Ashraf, M. U., & Batool, N. (2021) · Current Drug Delivery · doi:10.2174/1567201818666210212085912 · Cited by 18
Enhancing Chemotherapy by RNA Interference
Cao, S., Lin, C., Liang, S., Tan, C. H., Saw, P. E., & Xu, X. (2020) · BIO Integration · doi:10.15212/bioi-2020-0003 · Cited by 17 · cited 1×
“They enhance the drug efficacy in colorectal cancer treatment (Shu et al., 2020).”
BackgroundKawano, S., Lie, J., Ohgi, R., Shizuma, M., & Muraoka, M. (2021) · Macromolecules · doi:10.1021/acs.macromol.1c00265 · Cited by 16 · cited 1×
“Recently, a kind of micellar-like polymeric amphiphile modulated by host–guest interactions in the presence of a lipophilic dye to induce assembly and phase transition under precise pH control was studied (Figure 3) (Kawano et al., 2021).”
BackgroundBiodegradable polymersomes from four‐arm PEG‐b‐PDLLA for encapsulating hemoglobin
Li, W., Zhang, W., Yang, X., Xie, Z., & Jing, X. (2014) · Journal of Applied Polymer Science · doi:10.1002/app.40433 · Cited by 13 · cited 1×
“Polymersomes can also be used as carriers for artificial oxygen (Wen et al., 2014).”
BackgroundSelf-citationXu, J., Tang, J., Zhao, L., & Shen, Y. (2009) · PubMed · Cited by 12
Wang, X., Xu, L., Li, M., & Zhang, X. (2020) · Angewandte Chemie · doi:10.1002/ange.202008858 · Cited by 10
Palacio-Castañeda, V., Egberink, R. O., Sait, A., Andrée, L., Sala, B. M., Besheli, N. H., Oosterwijk, E., Nilvebrant, J., Leeuwenburgh, S. C. G., Brock, R. E., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111944 · Cited by 8
Cited by
Samad, M. A., Ahmad, I., Zughaibi, T. A., Suhail, M., Zaidi, S. K., Al-Abbasi, F. A., & Tabrez, S. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100268 · Cited by 35
Mu, X., Mu, C., Wang, M., Meng, C., Liu, H., & Lu, H. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s552644 · Cited by 16
A Review on Scattering Techniques for Analysis of Nanomaterials and Biomaterials
Bihar Veterinary College, S., Prasad, R. D., Koshi College, B. S., Prasad, N. R., School of Nanoscience and Technology Shivaji University, M. S., Prasad, N., Department of Education, C. U., Prasad, S. R., Electronics and Telecommunication Department, D. C. O. E., Prasad, R. S., et al. (2024) · Engineered Science · doi:10.30919/es1332 · Cited by 5
Metadata
- Authors
- Xiao, X., Teng, F., Shi, C., Chen, J., Wu, S., Wang, B., Meng, X., Essiet Imeh, A., & Li, W.
- Venue
- Frontiers in Bioengineering and Biotechnology
- Publisher
- Frontiers Media SA
- Published
- 2022-10-07
- Volume
- 10
- Pages
- 1024143-1024143
- ISSN
- 2296-4185 (ISSN-L)
- OpenAlex
- W4303044684
- Cited by
- 176
- References
- 120
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.